OS Therapies OSTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$10.4M+22.8% | -$13.46M-95.7% | -$6.88M-51.6% | -$4.54M-17.0% | -$3.88M-29.6% | ||
| $124.94K0.0% | $124.94K0.0% | $124.94K+11.0% | $112.51K+16,089% | $695-50.0% | ||
| $1.44M-10.5% | $1.6M+96.9% | $814.93K-10.0% | $905.18K-3.8% | $941.28K+1,303% | ||
| $68.97K— | —— | —— | —— | -$1.12M— | ||
| $3.88M+281% | $1.02M— | —— | —— | -$202.28K-190% | ||
| -$63.08K+81.5% | -$340.13K+2.5% | -$348.75K— | —— | —— | ||
| -$6.37K— | —— | —— | —— | —— | ||
| -$4.56M-22.3% | -$3.73M+20.7% | -$4.71M-99.4% | -$2.36M+31.4% | -$3.44M-44.9% | ||
| —— | —— | —— | $316.42K+111% | $150K— | ||
| $7.35M-16.4% | $8.8M+134% | $3.76M+50.2% | $2.5M+90.9% | $1.31M+50.4% | ||
| —— | —— | —— | -$292.79K-68.6% | -$173.64K— | ||
| $1.84M— | —— | —— | —— | —— | ||
| —— | —— | $1.05M+163% | $400K-29.6% | $568.24K— | ||
| —— | —— | —— | —— | $0— | ||
| $5.21M+145% | $2.12M-43.8% | $3.78M+52.2% | $2.48M+136% | $1.05M-82.6% | ||
| $647.72K+140% | -$1.61M-73.6% | -$925.39K-448% | -$168.99K+93.4% | -$2.56M-170% | ||
| $124.24K— | —— | —— | —— | $0+100% | ||
| $1.44M-10.5% | $1.6M+96.8% | $814.93K-10.0% | $905.18K-3.8% | $941.28K+251% | ||
| $68.97K— | —— | —— | —— | -$1.12M— | ||
| —— | —— | —— | —— | $568.24K— | ||
| -$6.37K— | —— | —— | —— | —— | ||
| -$37.08K— | —— | —— | -$270+99.7% | -$96.99K— | ||
| -$63.08K+81.5% | -$340.13K+2.5% | -$348.75K— | —— | —— | ||
| $289.2K— | $0-100% | $239.25K+2,293% | $10K-97.1% | $346.59K+5,445% | ||
| -$10.4M+22.8% | -$13.46M-95.7% | -$6.88M-51.6% | -$4.54M-17.0% | -$3.88M-29.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $23.64K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $1.05M-30.4% | ||
| —— | $33.55K0.0% | $33.55K0.0% | $33.55K0.0% | $33.55K-39.8% | ||
| —— | —— | —— | —— | $722.22K— | ||
| —— | $27.5K0.0% | $27.5K0.0% | $27.5K0.0% | $27.5K— | ||
| -$0.27+34.1% | -$0.41-95.2% | -$0.21-10.5% | -$0.19-5.6% | -$0.18+71.9% | ||
| -$0.27+34.1% | -$0.41-95.2% | -$0.21-10.5% | -$0.19-5.6% | -$0.18+71.9% | ||
| 50%0.0% | 50%— | —— | —— | 50%0.0% | ||
| —— | —— | —— | -$302.04K+73.1% | -$1.12M+43.1% | ||
| $2.82M-11.7% | $3.19M+2.1% | $3.12M+33.6% | $2.34M-36.6% | $3.69M+76.1% | ||
| —— | $625K0.0% | $625K0.0% | $625K0.0% | $625K— | ||
| $75.34K— | —— | —— | —— | —— | ||
| $45-16.7% | $54-16.9% | $65+1.6% | $64-3.0% | $66— | ||
| $22.38M— | —— | —— | —— | $22.38M+300% | ||
| -$228.89K+84.5% | -$1.47M-2,266,163% | $65-100.0% | $302.11K-73.1% | $1.12M+4,625% | ||
| -$10.17M+15.2% | -$11.99M-74.3% | -$6.88M-42.2% | -$4.84M+3.2% | -$5M-68.5% | ||
| —— | 10%— | —— | —— | —— | ||
| $0— | —— | —— | —— | $0-100% | ||
| $266.32K+300% | $66.58K0.0% | $66.58K0.0% | $66.58K0.0% | $66.58K— | ||
| $3.38M+2,447% | $132.54K0.0% | $132.54K0.0% | $132.54K0.0% | $132.54K— | ||
| $15.13K+300% | $3.78K0.0% | $3.78K0.0% | $3.78K0.0% | $3.78K— | ||
| $2.43K-50.1% | $4.88K— | $0-100% | $2.36K-25.0% | $3.15K+620% | ||
| 112%0.0% | 112%— | —— | —— | —— | ||
| 3.8%+0.2% | 3.6%— | —— | —— | —— | ||
| —— | —— | —— | —— | $1.45M— | ||
| $125— | —— | —— | —— | —— | ||
| 38.7M+32.2% | 29.3M-8.5% | 32M+27.2% | 25.1M+18.2% | 21.2M+206% | ||
| —— | -$3.73M+20.7% | -$4.71M-75.8% | -$2.68M+25.5% | -$3.59M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does OS Therapies generate?
- OS Therapies (OSTX) generated -$15.4M in operating cash flow over the trailing twelve months.
- What is OS Therapies's free cash flow?
- OS Therapies's free cash flow was -$14.7M over the trailing twelve months.
- Where does OS Therapies's cash flow data come from?
- Every line is extracted from OS Therapies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.